Compounds > imiquimod
Page last updated: 2024-08-24

imiquimod and itraconazole

imiquimod has been researched along with itraconazole in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Al-Mutairi, N; Alshiltawy, M; Darwish, I; Eassa, BI; El Khalawany, M; Gomaa, S; Joshi, A; Manchanda, Y; Rijhwani, M1
Cai, Q; Chen, J; Chen, WR; Hu, C; Luo, M; Mo, X; Shi, L; Wang, X; Yang, L; Zhang, F; Zhang, G1
Belda, W; Criado, PR; Domingues Passero, LF1

Other Studies

5 other study(ies) available for imiquimod and itraconazole

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Tropical medicine rounds: Treatment of Old World cutaneous leishmaniasis with dapsone, itraconazole, cryotherapy, and imiquimod, alone and in combination.
    International journal of dermatology, 2009, Volume: 48, Issue:8

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Ambulatory Care Facilities; Aminoquinolines; Anti-Infective Agents; Antiprotozoal Agents; Combined Modality Therapy; Cryotherapy; Dapsone; Drug Therapy, Combination; Female; Humans; Imiquimod; Itraconazole; Kuwait; Leishmaniasis, Cutaneous; Male; Middle Aged; Treatment Outcome; Young Adult

2009
In situ photoimmunotherapy for cutaneous granuloma caused by itraconazole-resistant Candida guilliermondii.
    Dermatologic therapy, 2016, Volume: 29, Issue:5

    Topics: Adjuvants, Immunologic; Aged, 80 and over; Aminoquinolines; Antifungal Agents; Biopsy; Candidiasis, Cutaneous; Drug Resistance, Fungal; Granuloma; Humans; Imiquimod; Immunotherapy; Itraconazole; Lasers, Semiconductor; Male; Phototherapy; Treatment Outcome

2016
Case Report: Treatment of Chromoblastomycosis with Combinations including Acitretin: A Report of Two Cases.
    The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:5

    Topics: Acitretin; Adjuvants, Immunologic; Antifungal Agents; Chromoblastomycosis; Drug Therapy, Combination; Humans; Imiquimod; Itraconazole; Keratolytic Agents; Male; Middle Aged

2020